// App-Quantinova.ai

: Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: MPN Experimental Assessment of Symptoms By Utilizing Repetitive Evaluation (MEASURE) Trial

Researchers

Presenter

  • Allison Gathany

Principal Investigators

  • Marlene Girardo

  • Heidi E. Kosiorek

  • Amylou C. Dueck

  • Holly Geyer

  • Veena D. S. Fauble

  • Alessandro M. Vannucchi

  • Ana Kerguelen Fuentes

  • Christen Lykkegaard Andersen

  • Elisabeth Ejerblad

  • Gunnar Birgegard

  • Peter L. Johansson

  • Bjorn Andreasson

  • David M Ross

  • Federico Sackman

  • Jean-Loup Demory

  • Constantine S. Tam

  • Jan J. Michiels

  • Deepti Radia

  • Joanne Ewing

  • Frances Wadelin

  • Robert N. Lown

  • Mary Frances McMullin

  • Wunna Swe

  • Jonathan O. Cullis

  • Nigel Sargant

  • Paul Moreton

  • Catherine Cargo

  • Mallika Sekhar

  • Satareh Shekouhi

  • Ruben A. Mesa

Medical Centers

  • Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH

  • Mays Cancer Center, UT Health San Antonio, San Antonio, TX, USA

  • Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN

  • Department of Bioinformatics, Mayo Clinic, Scottsdale, AZ

  • Biostatistics, Mayo Clinic Arizona, Scottsdale, AZ

  • Department of Medicine, Mayo Clinic, Phoenix, AZ

  • Honor Health System, Scottsdale, AZ

  • Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

  • Hematology, Roskilde University Hospital, Roskilde, Denmark

  • NU Hospital Organization, Internal Medicine, Uddevalla, Sweden

  • Uppsala University Hospital, Uppsala, Sweden

  • Uddevalla Hospital, Uddevalla, Sweden

  • Uddevalla Sjukhus, Uddavella, Sweden

  • Human Physiology, School of Medicine, Flinders University, Adelaide, Australia

  • Fundaleu, GATLA, Buenos Aires, ARG

  • Dept. of Hematology, Hopital St. Vincent, Lille, France

  • Department of Surgery, St Vincent's Hospital, Fitzroy, Australia

  • Goodheart Institute & Foundation Center Europe, Rotterdam, Netherlands

  • Department of Medical Oncology, Guys and St Thomas NHS Foundation Trust, London, United Kingdom

  • Heart of England NHS Foundation Trust, UHB, Birmingham, GBR

  • University of Nottingham, Nottingham, GBR

  • The Royal Marsden Hospital, London, United Kingdom

  • Queen's University Belfast, Belfast, United Kingdom

  • Calderdale & Huddersfield Royal Infirmary, Huddersfield, GBR

  • Salisbury District Hospital, Salisbury, GBR

  • Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom

  • Department of Haematology, Pinderfields General Hospital, Wakefield, United Kingdom

  • St James's University Hospital, Haematological Malignancy Diagnostic Service (HMDS), Leeds, United Kingdom

  • Royal Free Hospital, London, UK

  • Guy's Hospital, Clinical Haematology, London, United Kingdom

  • UT Health San Antonio Cancer Center, San Antonio, TX

Locations

  • United States

  • Spain

  • Denmark

  • Sweden

  • Australia

  • France

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved